---
title: "TLSA.US (TLSA.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/TLSA.US/news.md"
symbol: "TLSA.US"
name: "TLSA.US"
parent: "https://longbridge.com/en/quote/TLSA.US.md"
datetime: "2026-03-08T04:21:49.878Z"
locales:
  - [en](https://longbridge.com/en/quote/TLSA.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TLSA.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TLSA.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/TLSA.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/TLSA.US/news.md)


# TLSA.US (TLSA.US) — Related News

### [15:22 ETTwo Male Birth Control Options Advance Into Phase II Clinical Trials](https://longbridge.com/en/news/276374321.md)
*2026-02-19T20:23:57.000Z*
> NEXT Life Sciences has advanced two male contraceptive options, Plan A™ and NLS-133, into Phase II clinical trials. Plan

### [Tiziana Life Sciences (NASDAQ:TLSA) Trading Up 0.7%  - Here's What Happened](https://longbridge.com/en/news/276303919.md)
*2026-02-19T05:51:21.000Z*
> Tiziana Life Sciences (NASDAQ:TLSA) shares rose 0.7% to $1.40 during trading, with a volume decline of 61% from the aver

### [Tiziana Life Sciences Announces the Peer-Reviewed Publication of Clinical Study Results for Intranasal Foralumab | TLSA Stock News](https://longbridge.com/en/news/273111062.md)
*2026-01-20T08:15:00.000Z*
> Tiziana Life Sciences, Ltd. announced the peer-reviewed publication of its clinical study results for intranasal foralum

### [Tiziana Life Sciences Announces Closing of Oversubscribed $8.8 Million Registered Direct Offering of Ordinary Shares | TLSA Stock News](https://longbridge.com/en/news/272872610.md)
*2026-01-16T11:45:00.000Z*
> Tiziana Life Sciences, a biotechnology company, has successfully closed an oversubscribed registered direct offering of 

### [Tiziana Life Sciences closes $8.8 million direct offering of 7,040,000 ordinary shares at $1.25 each, with potential $10.56 million additional gross proceeds from warrants.](https://longbridge.com/en/news/272873697.md)
*2026-01-16T19:46:50.000Z*
> Tiziana Life Sciences, Ltd. has completed a direct offering of 7,040,000 ordinary shares at $1.25 each, raising $8.8 mil

### [Tiziana Life Sciences prices $8M registered direct offering](https://longbridge.com/en/news/272846598.md)
*2026-01-16T14:03:47.000Z*
> Tiziana Life Sciences prices $8M registered direct offering

### [Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $17.6 Million | TLSA Stock News](https://longbridge.com/en/news/272833794.md)
*2026-01-16T04:00:00.000Z*
> Tiziana Life Sciences, a biotechnology company, has announced a registered direct offering of approximately $17.6 millio